Warnex announces an exclusive licence with Ipsogen to market a … - Canada NewsWire (press release)
August 16th, 2007Warnex announces an exclusive licence with Ipsogen to market a …Canada NewsWire (press release), Canada - Aug 14, 2007Finding the JAK2 mutation is a major step forward in diagnosing myeloproliferative disorders for the wellbeing of all Canadians. …
Read full story